Identifying Oncogenic Ras Signaling Targets in Lung Adenocarcinomas
Author Information
Author(s): Sudhir Putty-Reddy, Hsu Chia-Lang, Wang Mei-Jung, Wang Yi-Ting, Chen Yu-Ju, Sung Ting-Yi, Hsu Wen-Lian, Yang Ueng-Cheng, Chen Jeou-Yuan
Primary Institution: Academia Sinica, Taipei, Taiwan
Hypothesis
The study aims to identify phosphorylation events and signaling pathways regulated by oncogenic Ras in lung adenocarcinomas.
Conclusion
The study reveals that oncogenic Ras regulates specific phosphorylation events and pathways that are crucial for lung adenocarcinoma development.
Supporting Evidence
- Ras is frequently mutated in lung cancer, leading to MAPK signaling activation.
- 77 phosphorylation events were identified as regulated by oncogenic Ras.
- 60% of Ras-targeted phosphorylation events involved proline-directed kinases.
- Pathway analysis revealed upregulation of MAPK signaling in lung adenocarcinoma cells.
- Different subsets of kinases were activated in adenocarcinoma versus large cell carcinoma.
Takeaway
Researchers looked at how a cancer gene called Ras affects cell signaling in lung cancer, finding important changes that could help us understand the disease better.
Methodology
The study used functional phosphoproteomics to analyze phosphorylation events in human bronchial epithelial cells with and without oncogenic Ras.
Potential Biases
Potential bias in the selection of cell lines and experimental conditions.
Limitations
The study primarily focuses on specific cell lines and may not fully represent all lung cancer types.
Participant Demographics
The study involved immortalized human bronchial epithelial cells and non-small cell lung cancer cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website